Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda
April 9, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
1 min read
False
Advertisement
Research News
Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
April 8, 2026
Circular single-stranded donors help recombinases bypass immune defenses, unlocking in vivo gene insertion
2 min read
Alzheimer’s Drug Lecanemab Works by “Switching On” the Brain’s Cleanup Cells
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
Review: Making Better Antibodies at Scale
April 6, 2026
A new review unpacks how GMP standards, evolving regulations, and emerging production technologies are reshaping monoclonal antibody manufacturing
3 min read
How AI is Reshaping Biologic Drug Discovery
April 6, 2026
Review charts rise of language models, AlphaFold, and generative AI in engineering next-generation therapeutics
2 min read
CAR-T Cells Target Alzheimer’s Plaques
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
CAR Tregs Move Into Neurodegeneration
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
From One Stem Cell to Millions of Cancer Killers
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
Mapping Carbon Hotspots in Pharma Supply Chains
March 30, 2026
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
1 min read
